Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 81
Filter
1.
Inorg Chem ; 60(2): 782-797, 2021 Jan 18.
Article in English | MEDLINE | ID: mdl-33411524

ABSTRACT

This combined experimental and computational study builds on our previous studies to elucidate the reaction mechanism of methanol oxidation by OsVIII oxido/hydroxido species (in basic aqueous media) while accounting for the simultaneous formation of OsVII species via a comproportionation reaction between OsVIII and OsVI. UV-Vis spectroscopy kinetic analyses with either CH3OH or the deuterated analogue CD3OH as a reducing agent revealed that transfer of α-carbon-hydrogen of methanol is the partial rate-limiting step. The resulting relatively large KIE value of approximately 11.82 is a combination of primary and secondary isotope effects. The Eyring plots for the oxidation of these isotopologues of methanol under the same reaction conditions are parallel to each other and hence have the same activation enthalpy [Δ⧧H° = 14.4 ± 1.2 kcal mol-1 (CH3OH) and 14.5 ± 1.3 kcal mol-1 (CD3OH)] but lowered activation entropy (Δ⧧S°) from -12.5 ± 4.1 cal mol-1 K-1 (CH3OH) to -17.1 ± 4.4 cal mol-1 K-1 (CD3OH). DFT computational studies at the PBE-D3 level with QZ4P (Os) and pVQZ (O and H) basis sets provide clear evidence to support the data and interpretations derived from the experimental kinetic work. Comparative DFT mechanistic investigations in a simulated aqueous phase (COSMO) indicate that methanol and OsVIII first associate to form a noncovalent adduct bound together by intermolecular H-bonding interactions. This is followed by spin-forbidden α-carbon-hydrogen transfer (not O-H transfer) from methanol to OsVIII by means of HAT, which is found to be the partial rate-limiting step. Without the organic and inorganic fragments dissociating from each other during the entire stepwise redox reaction (in order to avoid formation of highly energetically unfavorable monomer species), the HAT step is followed by PT and then ET before the final product monomers formaldehyde and OsVI dissociate from each other. DFT-calculated Δ⧧H° is within 5 kcal mol-1 of the experimentally obtained value, while the DFT Δ⧧S° is three times larger than that found from the experiment.

2.
Mol Biol Evol ; 33(10): 2621-32, 2016 10.
Article in English | MEDLINE | ID: mdl-27401231

ABSTRACT

Secreted ligands in the Dpp/BMP family drive dorsal-ventral (D/V) axis formation in all Bilaterian species. However, maternal factors regulating Dpp/BMP transcription in this process are largely unknown. We identified the BTB domain protein longitudinals lacking-like (lolal) as a modifier of decapentaplegic (dpp) mutations. We show that Lolal is evolutionarily related to the Trithorax group of chromatin regulators and that lolal interacts genetically with the epigenetic factor Trithorax-like during Dpp D/V signaling. Maternally driven Lolal(HA) is found in oocytes and translocates to zygotic nuclei prior to the point at which dpp transcription begins. lolal maternal and zygotic mutant embryos display significant reductions in dpp, pMad, and zerknullt expression, but they are never absent. The data suggest that lolal is required to maintain dpp transcription during D/V patterning. Phylogenetic data revealed that lolal is an evolutionarily new gene present only in insects and crustaceans. We conclude that Lolal is the first maternal protein identified with a role in dpp D/V transcriptional maintenance, that Lolal and the epigenetic protein Trithorax-like are essential for Dpp D/V signaling and that the architecture of the Dpp D/V pathway evolved in the arthropod lineage after the separation from vertebrates via the incorporation of new genes such as lolal.


Subject(s)
Drosophila Proteins/genetics , Drosophila melanogaster/genetics , Transcription Factors/genetics , Animals , Biological Evolution , Body Patterning , Drosophila Proteins/metabolism , Drosophila melanogaster/embryology , Epigenomics , Female , Male , Mutation , Phenotype , Phylogeny , Signal Transduction/genetics , Transcription Factors/metabolism , Transforming Growth Factor beta/genetics , Transforming Growth Factor beta/metabolism , Vertebrates/embryology , Vertebrates/metabolism
3.
Neuropsychologia ; 69: 130-9, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25600344

ABSTRACT

Effective self-control relies on the rapid adjustment of inappropriate responses. Understanding the brain basis of these processes has the potential to inform neurobiological models of the many neuropsychiatric disorders that are marked by maladaptive responding. Research on error processing in particular has implicated the dorsomedial frontal lobe (DMF) and basal ganglia (BG) in error detection, inhibition and correction. However there is controversy regarding the specific contributions of these regions to each of these component processes. Here we examined the effects of lesions affecting DMF or BG on these error-related processes. A flanker task was used to induce errors that in turn led to spontaneous, online corrections, while response kinematics were measured with high spatiotemporal resolution. The acceleration of errors was initially greater than that of correct responses. Errors then showed slower acceleration compared to correct responses, consistent with engagement of inhibition shortly after error response onset. BG damage disproportionately disrupted this early inhibitory phenomenon, above and beyond effects on baseline motor performance, but did not affect the kinematics of the corrective response. DMF damage showed the opposite pattern, with relatively delayed onset and weaker initial acceleration of the corrective response, but error suppression kinematics similar to that of the control group. This work clarifies the component processes and neural substrates of online post-error control, providing evidence for dissociable contributions of BG to error inhibition, but not correction, and DMF to rapid error correction, but not error suppression.


Subject(s)
Basal Ganglia/physiopathology , Frontal Lobe/physiopathology , Psychomotor Performance , Basal Ganglia/pathology , Biomechanical Phenomena , Brain Ischemia/pathology , Brain Ischemia/physiopathology , Brain Neoplasms/pathology , Brain Neoplasms/physiopathology , Brain Neoplasms/surgery , Feedback, Psychological , Female , Frontal Lobe/pathology , Hand/physiopathology , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Neuropsychological Tests , Psychomotor Performance/physiology , Reaction Time
4.
Anal Chim Acta ; 730: 93-8, 2012 Jun 12.
Article in English | MEDLINE | ID: mdl-22632050

ABSTRACT

A detailed analysis of the (35)Cl/(37)Cl isotope effects observed in the 19.11 MHz (103)Rh NMR resonances of [RhCl(n)(H(2)O)(6-n)](3-n) complexes (n=3-6) in acidic solution at 292.1K, shows that the 'fine structure' of each (103)Rh resonance can be understood in terms of the unique isotopologue and in certain instances the isotopomer distribution in each complex. These (35)Cl/(37)Cl isotope effects in the (103)Rh NMR resonance of the [Rh(35/37)Cl(6)](3-) species manifest only as a result of the statistically expected (35)Cl/(37)Cl isotopologues, whereas for the aquated species such as for example [Rh(35/37)Cl(5)(H(2)O)](2-), cis-[Rh(35/37)Cl(4)(H(2)O)(2)](-) as well as the mer-[Rh(35/37)Cl(3)(H(2)O)(3)] complexes, additional fine-structure due to the various possible isotopomers within each class of isotopologues, is visible. Of interest is the possibility of the direct identification of stereoisomers cis-[RhCl(4)(H(2)O)(2)](-), trans-[RhCl(4)(H(2)O)(2)](-), fac-[RhCl(3)(H(2)O)(3)] and mer-[RhCl(3)(H(2)O)(3)] based on the (103)Rh NMR line shape, other than on the basis of their very similar δ((103)Rh) chemical shift. The (103)Rh NMR resonance structure thus serves as a novel and unique 'NMR-fingerprint' leading to the unambiguous assignment of [RhCl(n)(H(2)O)(6-n)](3-n) complexes (n=3-6), without reliance on accurate δ((103)Rh) chemical shifts.

5.
Dalton Trans ; 40(34): 8581-8, 2011 Sep 14.
Article in English | MEDLINE | ID: mdl-21792440

ABSTRACT

A kinetic study of [OsO(4)] reduction by aliphatic alcohols (MeOH and EtOH) was performed in a 2.0 M NaOH matrix at 298.1 K. The rate model that best fitted the UV-VIS data supports a one-step, two electron reduction of Os(VIII) (present as both the [Os(VIII)O(4)(OH)](-) and cis-[Os(VIII)O(4)(OH)(2)](2-) species in a ratio of 0.34:0.66) to form the trans-[Os(VI)O(2)(OH)(4)](2-) species. The formed trans-[Os(VI)O(2)(OH)(4)](2-) species subsequently reacts relatively rapidly with the cis-[Os(VIII)O(4)(OH)(2)](2-) complex anion to form a postulated [Os(VII)O(3)(OH)(3)](2-) species according to: cis-[Os(VIII)O(4)(OH)(2)](2-) + trans-[Os(VI)O(2)(OH)(4)](2-) (k+2) <−> (k-2) 2[Os(VII)O(3)(OH)(3)](2-). The calculated forward, k(+2), and reverse, k(-2), reaction rate constants of this comproportionation reaction are 620.9 ± 14.6 M(-1) s(-1) and 65.7 ± 1.2 M(-1) s(-1) respectively. Interestingly, it was found that the postulated [Os(VII)O(3)(OH)(3)](2-) complex anion does not oxidize MeOH or EtOH. Furthermore, the reduction of Os(VIII) with MeOH or EtOH is first order with respect to the aliphatic alcohol concentration. In order to corroborate the formation of the [Os(VII)O(3)(OH)(3)](2-) species predicted with the rate model simulations, several Os(VIII)/Os(VI) mole fraction and mole ratio titrations were conducted in a 2.0 M NaOH matrix at 298.1 K under equilibrium conditions. These titrations confirmed that the cis-[Os(VIII)O(4)(OH)(2)](2-) and trans-[Os(VI)O(2)(OH)(4)](2-) species react in a 1:1 ratio with a calculated equilibrium constant, K(COM), of 9.3 ± 0.4. The ratio of rate constants k(+2) and k(-2) agrees quantitatively with K(COM), satisfying the principle of detailed balance. In addition, for the first time, the molar extinction coefficient spectrum of the postulated [Os(VII)O(3)(OH)(3)](2-) complex anion is reported.

6.
PLoS One ; 6(2): e16799, 2011 Feb 25.
Article in English | MEDLINE | ID: mdl-21364917

ABSTRACT

Mutations in the human mitochondrial elongation factor G1 (EF-G1) are recessive lethal and cause death shortly after birth. We have isolated mutations in iconoclast (ico), which encodes the highly conserved Drosophila orthologue of EF-G1. We find that EF-G1 is essential during fly development, but its function is not required in every tissue. In contrast to null mutations, missense mutations exhibit stronger, possibly neomorphic phenotypes that lead to premature death during embryogenesis. Our experiments show that EF-G1 contains a secondary C-terminal nuclear localization signal. Expression of missense mutant forms of EF-G1 can accumulate in the nucleus and cause growth and patterning defects and animal lethality. We find that transgenes that encode mutant human EF-G1 proteins can rescue ico mutants, indicating that the underlying problem of the human disease is not just the loss of enzymatic activity. Our results are consistent with a model where EF-G1 acts as a retrograde signal from mitochondria to the nucleus to slow down cell proliferation if mitochondrial energy output is low.


Subject(s)
Drosophila Proteins/chemistry , Drosophila Proteins/metabolism , Drosophila Proteins/physiology , Drosophila/embryology , Drosophila/genetics , Nuclear Localization Signals , Peptide Elongation Factor G/chemistry , Peptide Elongation Factor G/genetics , Peptide Elongation Factor G/physiology , Peptide Elongation Factors/chemistry , Peptide Elongation Factors/physiology , Amino Acid Sequence , Animals , Animals, Genetically Modified , Down-Regulation/genetics , Drosophila/growth & development , Drosophila/metabolism , Drosophila Proteins/genetics , Embryo, Nonmammalian , Female , Gene Expression Regulation, Developmental , Genes, Lethal , Humans , Male , Mitochondrial Proteins/chemistry , Mitochondrial Proteins/genetics , Mitochondrial Proteins/metabolism , Mitochondrial Proteins/physiology , Molecular Sequence Data , Nuclear Localization Signals/chemistry , Nuclear Localization Signals/genetics , Nuclear Localization Signals/physiology , Peptide Elongation Factor G/metabolism , Peptide Elongation Factors/genetics , Peptide Elongation Factors/metabolism , Sequence Homology, Amino Acid , Signal Transduction/genetics
7.
Talanta ; 82(1): 348-58, 2010 Jun 30.
Article in English | MEDLINE | ID: mdl-20685477

ABSTRACT

A hyphenated ion-pair (tetrabutylammonium chloride-TBACl) reversed phase (C(18)) HPLC-ICP-MS method (High Performance Liquid Chromatography Inductively Coupled Plasma Mass Spectroscopy) for anionic Rh(III) aqua chlorido-complexes present in an HCl matrix has been developed. Under optimum chromatographic conditions it was possible to separate and quantify cationic Rh(III) complexes (eluted as a single band), [RhCl(3)(H(2)O)(3)], cis-[RhCl(4)(H(2)O)(2)](-), trans-[RhCl(4)(H(2)O)(2)](-) and [RhCl(n)(H(2)O)(6-n)](3-n) (n=5, 6) species. The [RhCl(n)(H(2)O)(6-n)](3-n) (n=5, 6) complex anions eluted as a single band due to the relatively fast aquation of [RhCl(6)](3-) in a 0.1 mol L(-1) TBACl ionic strength mobile phase matrix. Moreover, the calculated t(1/2) of 1.3 min for [RhCl(6)](3-) aquation at 0.1 mol kg(-1) HCl ionic strength is significantly lower than the reported t(1/2) of 6.3 min at 4.0 mol kg(-1) HClO(4) ionic strength. Ionic strength or the activity of water in this context is a key parameter that determines whether [RhCl(n)(H(2)O)(6-n)](3-n) (n=5, 6) species can be chromatographically separated. In addition, aquation/anation rate constants were determined for [RhCl(n)(H(2)O)(6-n)](3-n) (n=3-6) complexes at low ionic strength (0.1 mol kg(-1) HCl) by means of spectrophotometry and independently with the developed ion-pair HPLC-ICP-MS technique for species assignment validation. The Rh(III) samples that was equilibrated in differing HCl concentrations for 2.8 years at 298K was analyzed with the ion-pair HPLC method. This analysis yielded a partial Rh(III) aqua chlorido-complex species distribution diagram as a function of HCl concentration. For the first time the distribution of the cis- and trans-[RhCl(4)(H(2)O)(2)](-) stereoisomers have been obtained. Furthermore, it was found that relatively large amounts of 'highly' aquated [RhCl(n)(H(2)O)(6-n)](3-n) (n=0-4) species persist in up to 2.8 mol L(-1) HCl and in 1.0 mol L(-1) HCl the abundance of the [RhCl(5)(H(2)O)](2-) species is only 8-10% of the total, far from the 70-80% as previously proposed. A 95% abundance of the [RhCl(6)](3-) complex anion occurs only when the HCl concentration is above 6 mol L(-1). The detection limit for a Rh(III) species eluted from the column is below 0.147 mg L(-1).

8.
Mech Dev ; 127(7-8): 358-70, 2010.
Article in English | MEDLINE | ID: mdl-20381612

ABSTRACT

The goal of this report is to elucidate the contributions of the Drosophila TGF-beta type I receptors TKV and SAX to the activity gradient formed by the two BMP family members DPP and GBB that play important roles in growth and patterning of imaginal discs. Binding studies display preferential interactions of DPP and GBB with homodimers of TKV or SAX, respectively, but also low affinities of both ligands to heterodimers. Inside the cell, constitutively activated forms of both TKV and SAX can ectopically phosphorylate the SMAD transcription factor MAD. However, MAD phosphorylated by homodimers of activated SAX or certain mutant forms of TKV localizes to the nucleus without changing the expression of downstream genes. Differences in signaling between SAX and TKV can be localized to amino acid residues within an area that has been shown to influence complexes formation between type I and type II receptors. The finding that the type II receptor PUT but not activated forms of SAX can enhance signaling of a pseudo-activated MAD-SDVD, which cannot be phosphorylated at the C-terminus, suggests a model, where activation of SMADs requires the presence of type II receptors and a second activation step in addition to C-terminal phosphorylation. Complete activation of MAD can only occur in tetrameric complexes of type II receptors in combination with SAX-TKV heterodimers or TKV homodimers but not SAX homodimers. Since TKV is not distributed equally in wing discs, heterodimers of SAX and TKV play an important role in extending the BMP activity gradient by facilitating DPP diffusion and assisting GBB signaling through functional complexes with type II receptors.


Subject(s)
DNA-Binding Proteins/metabolism , Drosophila Proteins/metabolism , Drosophila melanogaster/metabolism , Protein Serine-Threonine Kinases/metabolism , Receptors, Cell Surface/metabolism , Receptors, Transforming Growth Factor beta/metabolism , Smad Proteins/metabolism , Transcription Factors/metabolism , Animals , Drosophila Proteins/chemistry , Genetic Complementation Test , Ligands , Mutant Proteins/chemistry , Mutant Proteins/metabolism , Mutation/genetics , Phosphorylation , Protein Binding , Protein Multimerization , Protein Serine-Threonine Kinases/chemistry , Protein Structure, Secondary , Protein Structure, Tertiary , Receptors, Cell Surface/chemistry , Receptors, Transforming Growth Factor beta/chemistry , Signal Transduction , Wings, Animal/metabolism
9.
Mech Dev ; 125(1-2): 117-29, 2008.
Article in English | MEDLINE | ID: mdl-18077144

ABSTRACT

Follistatin (FS) is one of several secreted proteins that modulate the activity of TGF-beta family members during development. The structural and functional analysis of Drosophila Follistatin (dFS) reveals important differences between dFS and its vertebrate orthologues: it is larger, more positively charged, and proteolytically processed. dFS primarily inhibits signaling of Drosophila Activin (dACT) but can also inhibit other ligands like Decapentaplegic (DPP). In contrast, the presence of dFS enhances signaling of the Activin-like protein Dawdle (DAW), indicating that dFS exhibits a dual function in promoting and inhibiting signaling of TGF-beta ligands. In addition, FS proteins may also function in facilitating ligand diffusion. We find that mutants of daw are rescued in significant numbers by expression of vertebrate FS proteins. Since two PiggyBac insertions in dfs are not lethal, it appears that the function of dFS is non-essential or functionally redundant.


Subject(s)
Follistatin/metabolism , Transforming Growth Factor beta/metabolism , Animals , Base Sequence , DNA Primers , Drosophila , Follistatin/chemistry , Follistatin/genetics , Hydrolysis , Immunohistochemistry , In Situ Hybridization , Ligands , Phenotype , Protein Binding , Protein Conformation
10.
Fly (Austin) ; 1(4): 212-21, 2007.
Article in English | MEDLINE | ID: mdl-18820452

ABSTRACT

Growth factors of the TGF-beta family signal through type I/II receptor complexes that phosphorylate SMAD transcription factors. In this study, we analyzed signaling of all seven TGF-beta members to identify those that mediate growth through the Drosophila type I receptor BABO. We find that two potential ligands of BABO, Myoglianin (MYO) and Maverick (MAV), do not activate dSMAD2. Only Drosophila Activin (dACT) and the Activin-like ligand Dawdle (DAW) signal through BABO in combination with the type II receptor PUNT and activate dSMAD2. Surprisingly, we find that activation of BABO can also lead to the phosphorylation of the "BMP-specific" MAD. In wing discs, expression of an activated form of dSMAD2 promotes growth similar to dACT and activated BABO. By itself, activated dSMAD2 does not affect DPP/GBB target genes. However, coexpression of activated forms of dSMAD2 and MAD additively induces the expression of spalt. In contrast to dACT, we find that DAW does not promote growth when expressed in wings. In fact, coexpression of DAW with MAD or dSMAD2 decreases growth. daw mutants die primarily during larval stages and exhibit anal pad phenotypes reminiscent of babo mutants. The rescue of daw mutants by restricted expression in neuroendocrine cells indicates that Activin-type ligands are likely distributed through the endocrine system. The distinct signaling of dACT, DAW and MYO through BABO suggests the existence of co-receptors that modulate the canonical SMAD pathway.


Subject(s)
Activins/metabolism , Drosophila Proteins/metabolism , Drosophila melanogaster/metabolism , Signal Transduction , Transforming Growth Factor beta/metabolism , Activin Receptors/metabolism , Animals , DNA-Binding Proteins/metabolism , Drosophila melanogaster/embryology , Smad2 Protein/metabolism , Transcription Factors/metabolism , Wings, Animal/embryology , Wings, Animal/metabolism
11.
Cell ; 112(3): 303-15, 2003 Feb 07.
Article in English | MEDLINE | ID: mdl-12581521

ABSTRACT

Metamorphosis of the Drosophila brain involves pruning of many larval-specific dendrites and axons followed by outgrowth of adult-specific processes. From a genetic mosaic screen, we recovered two independent mutations that block neuronal remodeling in the mushroom bodies (MBs). These phenotypically indistinguishable mutations affect Baboon function, a Drosophila TGF-beta/activin type I receptor, and dSmad2, its downstream transcriptional effector. We also show that Punt and Wit, two type II receptors, act redundantly in this process. In addition, knocking out dActivin around the mid-third instar stage interferes with remodeling. Binding of the insect steroid hormone ecdysone to distinct ecdysone receptor isoforms induces different metamorphic responses in various larval tissues. Interestingly, expression of the ecdysone receptor B1 isoform (EcR-B1) is reduced in activin pathway mutants, and restoring EcR-B1 expression significantly rescues remodeling defects. We conclude that the Drosophila Activin signaling pathway mediates neuronal remodeling in part by regulating EcR-B1 expression.


Subject(s)
Brain/growth & development , Cell Differentiation/genetics , Drosophila/growth & development , Neural Pathways/growth & development , Neuronal Plasticity/genetics , Proteins , Receptors, Steroid/metabolism , Transforming Growth Factor beta/metabolism , Activin Receptors, Type I/deficiency , Activin Receptors, Type I/genetics , Activin Receptors, Type II/deficiency , Activin Receptors, Type II/genetics , Animals , Brain/cytology , Brain/metabolism , DNA-Binding Proteins/deficiency , DNA-Binding Proteins/genetics , Drosophila/cytology , Drosophila/metabolism , Drosophila Proteins/deficiency , Drosophila Proteins/genetics , Female , Genes, Lethal/genetics , Larva/cytology , Larva/growth & development , Larva/metabolism , Male , Mushroom Bodies/cytology , Mushroom Bodies/growth & development , Mushroom Bodies/metabolism , Mutation, Missense/genetics , Neural Pathways/cytology , Neural Pathways/metabolism , Neurons/cytology , Neurons/metabolism , Protein Isoforms/genetics , Protein Isoforms/metabolism , Receptors, Cell Surface/deficiency , Receptors, Cell Surface/genetics , Receptors, Steroid/genetics , Signal Transduction/genetics , Smad2 Protein , Trans-Activators/deficiency , Trans-Activators/genetics
12.
Gene ; 291(1-2): 85-93, 2002 May 29.
Article in English | MEDLINE | ID: mdl-12095682

ABSTRACT

With the genomic sequence of multicellular organisms such as Caenorhabditis elegans, Drosophila melanogaster, and Homo sapiens completed and others to be finished in the near future, the focus has shifted from accumulating sequence information to the prediction and analysis of genes within the completed genomes. Unfortunately, presently available computer programs do not always accurately predict gene structure such as mRNA and translation start sites or intron/exon boundaries. The only way to be certain about a gene's structure is to isolate and characterize its cDNA. Since the screening of libraries is a time-consuming, labor-intensive process that sometimes fails to yield the desired clone, we searched for faster, more efficient ways to isolate cDNAs. In this study, we describe two methods for amplification and isolation of cDNAs from plasmid libraries that requires no hybridization (MACH). With the polymerase chain reaction-based MACH-2 protocol, we present a strategy that requires little DNA sequence information to selectively isolate the longest cDNA variant from plasmid libraries in about 3 days. Our protocols were used to isolate cDNAs for the Drosophila activin and follistatin genes.


Subject(s)
Activins/genetics , DNA, Complementary/isolation & purification , Drosophila/genetics , Nucleic Acid Amplification Techniques/methods , Amino Acid Sequence , Animals , Cloning, Molecular , DNA, Complementary/chemistry , DNA, Complementary/genetics , Follistatin , Molecular Sequence Data , Sequence Alignment , Sequence Analysis, DNA , Sequence Homology, Amino Acid
13.
Neuron ; 33(4): 529-43, 2002 Feb 14.
Article in English | MEDLINE | ID: mdl-11856528

ABSTRACT

Proper synaptic development is critical for establishing all aspects of neural function including learning, memory, and locomotion. Here, we describe the phenotypic consequences of mutations in the wishful thinking (wit) gene, the Drosophila homolog of the vertebrate BMP type II receptor. Mutations in wit result in pharate lethality that can be rescued by expression of a wit transgene in motor neurons but not in muscles. Mutant larvae exhibit small synapses, severe defects in evoked junctional potentials, a lower frequency of spontaneous vesicle release, and an alteration in the ultrastructure of synaptic active zones. These results reveal a novel role for BMP signaling in regulating Drosophila neuromuscular junction synapse assembly and activity and may indicate that similar pathways could govern vertebrate synapse development.


Subject(s)
Central Nervous System/abnormalities , Drosophila Proteins/genetics , Drosophila melanogaster/embryology , Gene Expression Regulation, Developmental/physiology , Mutation/physiology , Neuromuscular Junction/abnormalities , Protein Serine-Threonine Kinases/genetics , Receptors, Cell Surface/genetics , Transcription Factors , Animals , Body Patterning/genetics , Bone Morphogenetic Protein Receptors, Type II , Bone Morphogenetic Proteins/genetics , Bone Morphogenetic Proteins/metabolism , Cell Differentiation/genetics , Central Nervous System/growth & development , Central Nervous System/ultrastructure , DNA, Complementary/genetics , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Drosophila Proteins/isolation & purification , Drosophila melanogaster/growth & development , Drosophila melanogaster/ultrastructure , Female , Genes, Lethal/genetics , Immunohistochemistry , Male , Molecular Sequence Data , Motor Neurons/metabolism , Motor Neurons/ultrastructure , Neuromuscular Junction/growth & development , Neuromuscular Junction/ultrastructure , Neuronal Plasticity/genetics , Neurotransmitter Agents/genetics , Neurotransmitter Agents/metabolism , Phenotype , Protein Serine-Threonine Kinases/isolation & purification , Receptors, Cell Surface/isolation & purification , Sequence Homology, Amino Acid , Sequence Homology, Nucleic Acid , Signal Transduction/genetics
14.
Harefuah ; 132(6): 402-3, 447, 1997 Mar 16.
Article in Hebrew | MEDLINE | ID: mdl-9153855

ABSTRACT

From February 1990 to August 1995 we treated 58 patients with chronic hepatitis C alfa-interferon, 3 million units 3 times weekly for 6 months. Of the 48 patients with adequate follow-up, 34 did not respond to treatment at all. 10 patients responded, but within a few months hepatic enzymes again increased. These 2 groups can be considered failures of interferon treatment. In 4 patients enzymes remained normal for the duration of follow-up, (10-34 months). Even in this small group, 1 patient had a positive test for HCV RNA after completion of treatment. A partial explanation of our disappointing results may be the high prevalence of a subtype of C hepatitis-subtype 1b, which has recently been reported in Israel. This strain is particularly resistant to interferon. The means to define subtypes were not, and as far as we know are not yet available in Israel. Various groups have attempted to improve the outcome of treatment of hepatitis C, which in other hands too was still far from satisfactory. Thus, regimens of interferon utilizing higher doses and longer periods of treatment are being evaluated, as well as the addition of Ribavirin, which hopefully will improve results.


Subject(s)
Antiviral Agents/therapeutic use , Hepatitis C/therapy , Interferon-alpha/therapeutic use , Antiviral Agents/administration & dosage , Chronic Disease , Drug Administration Schedule , Follow-Up Studies , Humans , Interferon-alpha/administration & dosage , Treatment Outcome
15.
Harefuah ; 130(12): 817-9, 879, 1996 Jun 16.
Article in Hebrew | MEDLINE | ID: mdl-8885504

ABSTRACT

Drug-induced meningitis is rarely included in the differential diagnosis of aseptic (usually recurrent) meningitis. A 74-year-old man who suffered from recurrent aseptic meningitis following re-exposures to trimethoprim-sulphamethoxazole (Resprim) is presented. The clinical and laboratory findings resembled those found in bacterial meningitis, excluding normal glycorrachia. Extensive microbiological, serologic and imaging studies did not disclose any relevant findings. All symptoms and signs resolved rapidly following drug withdrawal, and findings on follow-up lumbar puncture were normal.


Subject(s)
Anti-Infective Agents/adverse effects , Meningitis/chemically induced , Trimethoprim, Sulfamethoxazole Drug Combination/adverse effects , Aged , Diagnosis, Differential , Humans , Male , Meningitis/diagnosis , Meningitis/physiopathology
16.
Harefuah ; 128(11): 703-7, 1995 Jun 01.
Article in Hebrew | MEDLINE | ID: mdl-7557670
17.
MD Comput ; 12(3): 159-61, 1995.
Article in English | MEDLINE | ID: mdl-7596243
18.
Br J Cancer ; 71(1): 48-51, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7819047

ABSTRACT

Chemotherapy with the cytotoxic drug procarbazine (PCB) causes permanent infertility in most male patients. Since many patients treated with this cytotoxic drug are of reproductive age, it is important to develop a method to protect spermatogenesis and fertility. It has been hypothesised that 'spermatogenic arrest' by pharmacological intervention may render the testes less susceptible to the effects of chemotherapy. The present study investigated whether recovery of fertility in a male rat model could be achieved by suppression of spermatogenesis with high doses of clomiphene citrate (CC) prior to PCB administration. It was demonstrated that young male rats treated with a combination of CC and PCB partially recovered spermatogenesis and achieved almost normal fertility. In contrast, animals treated with PCB alone exhibited abnormal spermatogenesis and remained infertile.


Subject(s)
Clomiphene/pharmacology , Infertility, Male/chemically induced , Procarbazine/toxicity , Animals , Male , Rats , Rats, Wistar , Spermatogenesis/drug effects , Testis/drug effects , Testis/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...